PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG

被引：0
|
作者：
Bordonaro, Roberto [1 ]
Soto-Parra, Hector [1 ]
Pumo, Vitalinda [1 ]
Nacci, Angelo [2 ]
Latteri, Fiorenza [1 ]
Rizzo, Piero [2 ]
Cordio, Stefano [1 ]
Sambataro, Daniela [1 ]
Potenza, Enrico [3 ]
Cinieri, Saverio [2 ]
机构：
[1] ARNAS Garibaldi, Med Oncol Unit, Catania, Italy
[2] Perrino Hosp, Med Oncol & Breast Unit, Brindisi, Italy
[3] ARNAS Garibaldi, Thorac Surg Unit, Catania, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG: PRELIMINARY DATA OF SAFETY AND EFFICACY OF A PHASE II STUDY
    Bordonaro, R.
    Soto-Parra, H.
    Nacci, A.
    Latteri, F.
    Rizzo, P.
    Cordio, S.
    Salice, P.
    Sambataro, D.
    Potenza, E.
    Cinieri, S.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S94 - S94
  • [2] THE THREE-DRUGS REGIMEN CPBEV (CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB) IS VERY ACTIVE WHEN USED AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG: FINAL RESULTS OF A PHASE III TRIAL
    Bordonaro, Roberto
    Soto-Parra, Hector
    Sergi, Concetta
    Giannitto-Giorgio, Carmelo
    Cinieri, Saverio
    Latteri, Fiorenza
    Cordio, Stefano
    Martines, Concetta
    Burrafato, Giovanni
    Sambataro, Daniela
    Potenza, Enrico
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S884 - S884
  • [3] Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study.
    Bordonaro, Roberto
    Soto-Parra, Hector
    Giannitto-Giorgio, Carmelo
    Cinieri, Saverio
    Latteri, Fiorenza
    Sergi, Concetta
    Pappagallo, Giovanni L.
    Cordio, Stefano Sergio
    Salice, Placida
    Sambataro, Daniela
    Potenza, Enrico
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Adriamycin and cis-platinum as first-line treatment in unresectable locally advanced or metastatic adult soft-tissue sarcomas
    Kalofonos, HP
    Bafaloukos, D
    Kourelis, TG
    Karamouzis, MV
    Megas, P
    Iconomou, G
    Tsiata, E
    Dimitropoulos, D
    Kosmidis, P
    Lampiris, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 307 - 311
  • [5] Clinical Characteristics and Outcome for Patients with Advanced Lung Adenocarcinoma Treated with First-Line Pemetrexed Plus Platinum
    Ji, X.
    Hu, X.
    Zhu, Y.
    Liu, Y.
    Lin, L.
    Xing, P.
    Hao, X.
    Wang, Y.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S885 - S885
  • [6] Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
    Fleeman, N.
    Bagust, A.
    McLeod, C.
    Greenhalgh, J.
    Boland, A.
    Dundar, Y.
    Dickson, R.
    Smith, C. Tudur
    Davis, H.
    Green, J.
    Pearson, M.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 47 - 53
  • [7] Benefits of Metformin Combined with Pemetrexed-Based Platinum Doublets as a First-Line Therapy for Advanced Lung Adenocarcinoma Patients with Diabetes
    Wang, Jiun-Long
    Tsai, Yi-Ting
    Lin, Ching-Heng
    Cidem, Abdulkadir
    Staniczek, Theresa
    Chang, Gary Ro-Lin
    Yen, Chih-Ching
    Chen, Wei
    Chong, Kowit-Yu
    Chen, Chuan-Mu
    BIOMOLECULES, 2021, 11 (08)
  • [8] EFFECTIVENESS OF BEVACIZUMAB IN PATIENTS WITH LUNG ADENOCARCINOMA TREATED WITH PEMETREXED / CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY
    Magallanes, Manuel E.
    Cruz, Angelica
    Zincer, Fernando P.
    Bautista, Yolanda
    Aceves, Isabel E.
    Velazco, Monica S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S579 - S579
  • [9] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2012, 18 (01): : 70 - 71
  • [10] First-Line Therapy in locally advanced or metastatic Urothelial Cancer
    Rexer, H.
    ONKOLOGE, 2011, 17 (07): : 638 - 639
12345